Imaging strategies primarily based on fluorescence and bioluminescence have been necessary instruments in visualizing tumor development and finding out the impact of medication and immunotherapies on tumor immune microenvironment in animal fashions of most cancers.
Nonetheless, transgenic expression of overseas proteins could induce immune responses in immunocompetent syngeneic tumor transplant fashions and increase the efficacy of experimental medication.
On this research, we present that the expansion fee of Lewis lung carcinoma (LL/2) tumors was lowered after transduction of tdTomato and luciferase (tdTomato/Luc) in comparison with the parental cell line. tdTomato/Luc expression by LL/2 cells altered the tumor microenvironment by growing tumor-infiltrating lymphocytes (TILs) whereas inhibiting tumor-induced myeloid-derived suppressor cells (MDSCs).
Curiously, tdTomato/Luc expression didn’t alter the response of LL/2 tumors to anti-PD-1 and anti-CTLA-4 antibodies. These outcomes recommend that the usage of tdTomato/Luc-transduced most cancers cells to conduct research in immune competent mice could result in cell-extrinsic tdTomato/Luc-induced alterations in tumor progress and tumor immune microenvironment that have to be considered when evaluating the efficacy of anti-cancer medication and vaccines in immunocompetent animal fashions.
Secreted Phosphoprotein 1 Expression in Retinal Mononuclear Phagocytes Hyperlinks Murine to Human Choroidal Neovascularization
Age-related macular degeneration (AMD) represents the commonest reason for blindness within the aged within the Western world. An impairment of the outer blood-retina barrier and a localized inflammatory microenvironment trigger sprouting of choroidal neovascular membranes (CNV) in neovascular AMD which can be in intimate contact with surrounding myeloid cells, resembling retinal microglia, and in the end result in visible impairment.
The invention of novel goal molecules to intervene with angiogenesis and irritation is significant for future remedy approaches in AMD sufferers. To discover the transcriptional profile and the operate of retinal microglia at websites of CNV, we carried out a complete RNA-seq evaluation of retinal microglia within the mouse mannequin of laser-induced choroidal neovascularization (mCNV).
Right here, we recognized the angiogenic issue Osteopontin (Opn), often known as “secreted phosphoprotein 1” (Spp1), as some of the extremely expressed genes in retinal microglia in the midst of CNV formation. We confirmed the presence of SPP1 on the lesion web site in recruited retinal microglia in Cx3cr1 CreER:Rosa26-tdTomato reporter mice by confocal microscopy and in entire retinal tissue lysates by ELISA highlighting an enormous native manufacturing of SPP1.
Inhibition of SPP1 by intravitreal injection of an anti-SPP1 antibody considerably elevated the lesion measurement in comparison with IgG-treated management eyes. Consistent with our leads to rodents, we discovered an elevated SPP1 mRNA expression in surgically extracted human choroidal neovascular (hCNV) membranes by the quantitative RNA-seq method of huge evaluation of cDNA ends (MACE).
Quite a few IBA1+SPP1+ myeloid cells had been detected in human CNV membranes. Taken collectively, these outcomes spotlight the significance of SPP1 within the formation of CNV and doubtlessly provide new alternatives for therapeutic intervention by modulating the SPP1 pathway.
Defining vitamin D receptor expression within the mind utilizing a novel VDR Cre mouse
Vitamin D motion has been linked to a number of ailments regulated by the mind together with weight problems, diabetes, autism, and Parkinson’s. Nonetheless, the placement of the vitamin D receptor (VDR) within the mind shouldn’t be clear because of conflicting studies.
We discovered that two antibodies beforehand printed as particular in peripheral tissues aren’t particular within the mind. We thus created a brand new knockin mouse with cre recombinase expression beneath the management of the endogenous VDR promoter (VDRCre ). We demonstrated that the cre exercise within the VDRCre mouse mind (as reported by a cre-dependent tdTomato expression) is very overlapping with endogenous VDR mRNAs.
These VDR-expressing cells had been enriched in a number of mind areas together with the cortex, amygdala, caudate putamen, and hypothalamus amongst others. Within the hypothalamus, VDR partially colocalized with vasopressin, oxytocin, estrogen receptor-α, and β-endorphin to varied levels.
We additional functionally validated our mannequin by demonstrating that the endogenous VDR agonist 1,25-dihydroxyvitamin D activated all examined tdTomato+ neurons within the paraventricular hypothalamus however had no impact on neurons with out tdTomato fluorescence. Thus, we now have generated a brand new mouse device that enables us to visualise VDR-expressing cells and to characterize their features.
Heterogeneous transgene expression within the retinas of the TH-RFP, TH-Cre, TH-BAC-Cre and DAT-Cre mouse strains.
Transgenic mouse strains are important instruments for understanding the connectivity, physiology and performance of neuronal circuits, together with these within the retina. This report compares transgene expression within the retina of a tyrosine hydroxylase (TH)-red fluorescent protein (RFP) mouse line with three catecholamine-related Cre recombinase mouse strains [TH-bacterial artificial chromosome (BAC)-, TH-, and dopamine transporter (DAT)-Cre] that had been crossed with a ROSA26-tdTomato reporter line.

Retinas had been evaluated and immunostained with generally used antibodies together with these directed to TH, GABA and glycine to characterize the RFP or tdTomato fluorescent-labeled amacrine cells, and an antibody directed to RNA-binding protein with a number of splicing to establish ganglion cells.
In TH-RFP retinas, sorts 1 and a couple of dopamine (DA) amacrine cells had been recognized by their attribute mobile morphology and sort 1 DA cells by their expression of TH immunoreactivity. Within the TH-BAC-, TH-, and DAT-tdTomato retinas, lower than 1%, ∼ 6%, and 0%, respectively, of the fluorescent cells had been the anticipated sort 1 DA amacrine cells.
As a substitute, within the TH-BAC-tdTomato retinas, fluorescently labeled AII amacrine cells had been predominant, with some medium diameter ganglion cells. In TH-tdTomato retinas, fluorescence was in a number of neurochemical amacrine cell sorts, together with 4 varieties of polyaxonal amacrine cells. In DAT-tdTomato retinas, fluorescence was in GABA immunoreactive amacrine cells, together with two varieties of bistratified and two varieties of monostratified amacrine cells.
Though every of the Cre strains was generated with the intent to particularly label DA cells, our findings present a mobile variety in Cre expression within the grownup retina and point out the significance of cautious characterization of transgene labeling patterns. These mouse strains with their distinctive mobile labeling patterns can be helpful instruments for future research of retinal operate and visible processing.
A Comparability of Purple Fluorescent Proteins to Mannequin DNA Vaccine Expression by Complete Animal In Vivo Imaging.
DNA vaccines may be manufactured cheaply, simply and quickly and have carried out effectively in pre-clinical animal research. Nonetheless, medical trials have to date been disappointing, failing to evoke a robust immune response, presumably because of poor antigen expression.
To enhance antigen expression, improved know-how to watch DNA vaccine transfection effectivity is required. Within the present research, we in contrast plasmid encoded tdTomato, mCherry, Katushka, tdKatushka2 and luciferase as reporter proteins for entire animal in vivo imaging. The intramuscular, subcutaneous and tattooing routes had been in contrast and electroporation was used to reinforce expression.
We noticed that general, fluorescent proteins weren’t a superb device to evaluate expression from DNA plasmids, with a extremely heterogeneous response between animals. Of the proteins used, intramuscular supply of DNA encoding both tdTomato or luciferase gave the clearest sign, with some Katushka and tdKatushka2 sign noticed. Subcutaneous supply was weakly seen and nothing was noticed following DNA tattooing.
DNA encoding haemagglutinin was used to find out whether or not immune responses mirrored seen expression ranges. A protecting immune response towards H1N1 influenza was induced by all routes, even after a single dose of DNA, although qualitative variations had been noticed, with tattooing resulting in excessive antibody responses and subcutaneous DNA resulting in excessive CD8 responses.
TDT antibody |
|||
70R-13822 | Fitzgerald | 100 ug | EUR 386.4 |
Description: Affinity purified Rabbit polyclonal TDT antibody |
TdT Antibody |
|||
F41538-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: This gene is a member of the DNA polymerase type-X family and encodes a template-independent DNA polymerase that catalyzes the addition of deoxynucleotides to the 3'-hydroxyl terminus of oligonucleotide primers. In vivo, the encoded protein is expressed in a restricted population of normal and malignant pre-B and pre-T lymphocytes during early differentiation, where it generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Alternatively spliced transcript variants encoding different isoforms of this gene have been described. |
TdT Antibody |
|||
F41538-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
Description: This gene is a member of the DNA polymerase type-X family and encodes a template-independent DNA polymerase that catalyzes the addition of deoxynucleotides to the 3'-hydroxyl terminus of oligonucleotide primers. In vivo, the encoded protein is expressed in a restricted population of normal and malignant pre-B and pre-T lymphocytes during early differentiation, where it generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Alternatively spliced transcript variants encoding different isoforms of this gene have been described. |
TdT Antibody |
|||
R31581 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: Terminal Deoxynucleotidyl Transferase, also known as Terminal transferase, is a unique DNA polymerase that without template direction catalyzes the addition of deoxyribonucleotides onto the 3-prime-hydroxyl end of DNA primers. Its gene is mapped to the region 10q23-q24. And TdT cDNA contains an open reading frame of 1,530 basepairs corresponding to a protein containing 510 amino acids. TdT may be responsible for inserting nucleotides (N regions) at the V(H)-D and D-J(H) junctions of immunoglobulin genes. The enzyme is present in immature thymocytes, some bone marrow cells, transformed pre-B and pre-T cell lines, and leukemia cells. Additionally, TdT catalyses the addition of nucleotides to the 3' terminus of a DNA molecule. Unlike most DNA polymerases it does not require a template. The preferred substrate of this enzyme is a 3'-overhang, but it can also add nucleotides to blunt or recessed 3' ends. Cobalt is a necessary cofactor. |
TdT Antibody |
|||
RQ5034 | NSJ Bioreagents | 100ul | EUR 356.15 |
Description: Terminal deoxynucleotidyltransferase is a template-independent DNA polymerase which catalyzes the random addition of deoxynucleoside 5'-triphosphate to the 3'-end of a DNA initiator. One of the in vivo functions of this enzyme is the addition of nucleotides at the junction (N region) of rearranged Ig heavy chain and T-cell receptor gene segments during the maturation of B- and T-cells. [UniProt] |
TdT Antibody |
|||
V8399-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Terminal deoxynucleotidyltransferase (TdT) is a DNA polymerase which catalyzes the addition of deoxyribonucleotides onto the 3 termini of DNA. The human TdT gene maps to chromosome 10q24.1 and encodes a 510 amino acid protein. Human TdT is synthesized as a single chain peptide that elicits a minor preference for incorporation of deoxyribonucleotides over ribonucleotides forming DNA strands. It is present in immature thymocytes, some bone marrow cells, transformed pre-B and pre-T cell lines, and leukemia cells. |
TdT Antibody |
|||
V8399-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Terminal deoxynucleotidyltransferase (TdT) is a DNA polymerase which catalyzes the addition of deoxyribonucleotides onto the 3 termini of DNA. The human TdT gene maps to chromosome 10q24.1 and encodes a 510 amino acid protein. Human TdT is synthesized as a single chain peptide that elicits a minor preference for incorporation of deoxyribonucleotides over ribonucleotides forming DNA strands. It is present in immature thymocytes, some bone marrow cells, transformed pre-B and pre-T cell lines, and leukemia cells. |
TdT Antibody |
|||
V8399SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Terminal deoxynucleotidyltransferase (TdT) is a DNA polymerase which catalyzes the addition of deoxyribonucleotides onto the 3 termini of DNA. The human TdT gene maps to chromosome 10q24.1 and encodes a 510 amino acid protein. Human TdT is synthesized as a single chain peptide that elicits a minor preference for incorporation of deoxyribonucleotides over ribonucleotides forming DNA strands. It is present in immature thymocytes, some bone marrow cells, transformed pre-B and pre-T cell lines, and leukemia cells. |
TdT Antibody |
|||
V8536-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Terminal deoxynucleotidyltransferase (TdT) is a DNA polymerase which catalyzes the addition of deoxyribonucleotides onto the 3 termini of DNA. The human TdT gene maps to chromosome 10q24.1 and encodes a 510 amino acid protein. Human TdT is synthesized as a single chain peptide that elicits a minor preference for incorporation of deoxyribonucleotides over ribonucleotides forming DNA strands. TdT is present in immature thymocytes, some bone marrow cells, transformed pre-B and pre-T cell lines, and leukemia cells. |
TdT Antibody |
|||
V8536-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
Description: Terminal deoxynucleotidyltransferase (TdT) is a DNA polymerase which catalyzes the addition of deoxyribonucleotides onto the 3 termini of DNA. The human TdT gene maps to chromosome 10q24.1 and encodes a 510 amino acid protein. Human TdT is synthesized as a single chain peptide that elicits a minor preference for incorporation of deoxyribonucleotides over ribonucleotides forming DNA strands. TdT is present in immature thymocytes, some bone marrow cells, transformed pre-B and pre-T cell lines, and leukemia cells. |
TdT Antibody |
|||
V8536SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
Description: Terminal deoxynucleotidyltransferase (TdT) is a DNA polymerase which catalyzes the addition of deoxyribonucleotides onto the 3 termini of DNA. The human TdT gene maps to chromosome 10q24.1 and encodes a 510 amino acid protein. Human TdT is synthesized as a single chain peptide that elicits a minor preference for incorporation of deoxyribonucleotides over ribonucleotides forming DNA strands. TdT is present in immature thymocytes, some bone marrow cells, transformed pre-B and pre-T cell lines, and leukemia cells. |
pCDH-ME-APOE-Luc2-T2A-tdTomato Plasmid |
|||
PVT17253 | Lifescience Market | 2 ug | EUR 444 |
TdT antibody (PE) |
|||
61R-1359 | Fitzgerald | 100 ug | EUR 625.2 |
Description: Mouse monoclonal TdT antibody (PE) |
DNTT,TDT Antibody |
|||
abx232488-100ug | Abbexa | 100 ug | EUR 577.2 |
DNTT,TDT Antibody |
|||
abx232489-100ug | Abbexa | 100 ug | EUR 661.2 |
anti- DNTT,TDT antibody |
|||
FNab02488 | FN Test | 100µg | EUR 606.3 |
Description: Antibody raised against DNTT,TDT |
anti- DNTT,TDT antibody |
|||
FNab02489 | FN Test | 100µg | EUR 702 |
Description: Antibody raised against DNTT,TDT |
Anti-DNTT,TDT antibody |
|||
PAab02488 | Lifescience Market | 100 ug | EUR 426 |
Anti-DNTT,TDT antibody |
|||
PAab02489 | Lifescience Market | 100 ug | EUR 494.4 |
Anti-DNTT,TDT antibody |
|||
STJ11100551 | St John's Laboratory | 50 µl | EUR 471.6 |
Description: NA |
TdT Polyclonal Antibody |
|||
ABP54015-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of TdT from Human. This TdT antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human TdT at AA rangle: 350-430 |
TdT Polyclonal Antibody |
|||
ABP54015-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of TdT from Human. This TdT antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human TdT at AA rangle: 350-430 |
TdT Polyclonal Antibody |
|||
ABP54015-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of TdT from Human. This TdT antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human TdT at AA rangle: 350-430 |
TdT Polyclonal Antibody |
|||
ES5014-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against TdT from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
TdT Polyclonal Antibody |
|||
ES5014-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against TdT from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Polyclonal TdT Antibody (C-term) |
|||
APR03576G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TdT (C-term). This antibody is tested and proven to work in the following applications: |
Polyclonal DNTT / TdT Antibody (C-Terminus) |
|||
APR03224G | Leading Biology | 0.05ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human DNTT / TdT (C-Terminus). This antibody is tested and proven to work in the following applications: |
TdT Antibody / DNA nucleotidylexotransferase |
|||
V8860-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: Terminal deoxynucleotidyl transferase (TdT) is an unusual deoxynucleotide polymerizing enzyme with a molecular weight of about 58 kDa found normally only in B- and T-cell lymphoblasts/prelymphocytes. TdT generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Rare TdT-positive cells are regularly detected in thymus and bone marrow. Typically, TdT expression in the thymus is very variable from cell to cell since it is rapidly decreased in more mature T-cells. TdT-positive cells may occasionally be found in tonsils, lymph nodes and extranodal lymphoid tissue. Immunohistochemical detection of TdT has value in classification of malignant lymphomas and acute leukemias, particularly for the identification of pre-B and pre-T acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). |
TdT Antibody / DNA nucleotidylexotransferase |
|||
V8860-20UG | NSJ Bioreagents | 20ug | EUR 153.3 |
Description: Terminal deoxynucleotidyl transferase (TdT) is an unusual deoxynucleotide polymerizing enzyme with a molecular weight of about 58 kDa found normally only in B- and T-cell lymphoblasts/prelymphocytes. TdT generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Rare TdT-positive cells are regularly detected in thymus and bone marrow. Typically, TdT expression in the thymus is very variable from cell to cell since it is rapidly decreased in more mature T-cells. TdT-positive cells may occasionally be found in tonsils, lymph nodes and extranodal lymphoid tissue. Immunohistochemical detection of TdT has value in classification of malignant lymphomas and acute leukemias, particularly for the identification of pre-B and pre-T acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). |
TdT Antibody / DNA nucleotidylexotransferase |
|||
V8860SAF-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: Terminal deoxynucleotidyl transferase (TdT) is an unusual deoxynucleotide polymerizing enzyme with a molecular weight of about 58 kDa found normally only in B- and T-cell lymphoblasts/prelymphocytes. TdT generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Rare TdT-positive cells are regularly detected in thymus and bone marrow. Typically, TdT expression in the thymus is very variable from cell to cell since it is rapidly decreased in more mature T-cells. TdT-positive cells may occasionally be found in tonsils, lymph nodes and extranodal lymphoid tissue. Immunohistochemical detection of TdT has value in classification of malignant lymphomas and acute leukemias, particularly for the identification of pre-B and pre-T acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). |
TdT Antibody / DNA nucleotidylexotransferase |
|||
V8879-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: Terminal deoxynucleotidyl transferase (TdT) is an unusual deoxynucleotide polymerizing enzyme with a molecular weight of about 58 kDa found normally only in B- and T-cell lymphoblasts/prelymphocytes. TdT generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Rare TdT-positive cells are regularly detected in thymus and bone marrow. Typically, TdT expression in the thymus is very variable from cell to cell since it is rapidly decreased in more mature T-cells. TdT-positive cells may occasionally be found in tonsils, lymph nodes and extranodal lymphoid tissue. Immunohistochemical detection of TdT has value in classification of malignant lymphomas and acute leukemias, particularly for the identification of pre-B and pre-T acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). |
TdT Antibody / DNA nucleotidylexotransferase |
|||
V8879-20UG | NSJ Bioreagents | 20ug | EUR 153.3 |
Description: Terminal deoxynucleotidyl transferase (TdT) is an unusual deoxynucleotide polymerizing enzyme with a molecular weight of about 58 kDa found normally only in B- and T-cell lymphoblasts/prelymphocytes. TdT generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Rare TdT-positive cells are regularly detected in thymus and bone marrow. Typically, TdT expression in the thymus is very variable from cell to cell since it is rapidly decreased in more mature T-cells. TdT-positive cells may occasionally be found in tonsils, lymph nodes and extranodal lymphoid tissue. Immunohistochemical detection of TdT has value in classification of malignant lymphomas and acute leukemias, particularly for the identification of pre-B and pre-T acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). |
TdT Antibody / DNA nucleotidylexotransferase |
|||
V8879SAF-100UG | NSJ Bioreagents | 100ug | EUR 349.3 |
Description: Terminal deoxynucleotidyl transferase (TdT) is an unusual deoxynucleotide polymerizing enzyme with a molecular weight of about 58 kDa found normally only in B- and T-cell lymphoblasts/prelymphocytes. TdT generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Rare TdT-positive cells are regularly detected in thymus and bone marrow. Typically, TdT expression in the thymus is very variable from cell to cell since it is rapidly decreased in more mature T-cells. TdT-positive cells may occasionally be found in tonsils, lymph nodes and extranodal lymphoid tissue. Immunohistochemical detection of TdT has value in classification of malignant lymphomas and acute leukemias, particularly for the identification of pre-B and pre-T acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). |
Mouse Anti-Human TdT monoclonal antibody, clone JID782 |
|||
CABT-L2855-100uL500uL | Creative Diagnostics | 100 uL, 500 uL | EUR 602.4 |
Terminal Deoxynucleotidyl Transferase (TDT) Antibody |
|||
20-abx225150 | Abbexa |
|
|
Terminal Deoxynucleotidyl Transferase (TDT) Antibody |
|||
abx026325-400ul | Abbexa | 400 ul | EUR 627.6 |
Terminal Deoxynucleotidyl Transferase (TDT) Antibody |
|||
abx026325-80l | Abbexa | 80 µl | EUR 343.2 |
Terminal Deoxynucleotidyl Transferase (TDT) Antibody |
|||
abx019173-100ug | Abbexa | 100 ug | EUR 410.4 |
Terminal Deoxynucleotidyl Transferase (TDT) Antibody |
|||
abx019174-100ug | Abbexa | 100 ug | EUR 410.4 |
Terminal Deoxynucleotidyl Transferase (TDT) Antibody |
|||
abx028082-400ul | Abbexa | 400 ul | EUR 627.6 |
Terminal Deoxynucleotidyl Transferase (TDT) Antibody |
|||
abx028082-80l | Abbexa | 80 µl | EUR 343.2 |
Terminal Deoxynucleotidyl Transferase (TDT) Antibody |
|||
abx037830-100ug | Abbexa | 100 ug | EUR 469.2 |
We conclude that of the reporter proteins used, expression from DNA plasmids can finest be assessed utilizing tdTomato or luciferase. However, the disconnect between seen expression stage and immunogenicity means that in vivo entire animal imaging of fluorescent proteins has restricted utility for predicting DNA vaccine efficacy.